StonvexLoading…
StonvexCore line items from FLG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $27.00M | $17.00M | $12.00M | $6.00M |
Operating Income | $826.00M | $642.00M | $437.00M | $207.00M |
Net Income | $650.00M | $478.00M | $326.00M | $155.00M |
EPS (Diluted) | $3.77 | $0.96 | $0.66 | $0.31 |
Total Assets | $90.14B | $62.96B | $63.09B | $61.01B |
Total Liabilities | $81.32B | $56.21B | $56.27B | $54.10B |
Cash & Equivalents | $2.03B | $1.70B | $3.28B | $2.90B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $184.00M |
Shares Outstanding | 681.22M | 466.14M | 466.24M | 467.02M |